Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Fröhling

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Molecular & Cellular Oncology|April 14, 2022
Interdisciplinary team science to understand and intercept rare cancersStefan Fröhling
Med (New York, N.Y.)|December 10, 2022
Toward defining the clinically actionable genome of metastatic breast cancerStefan Fröhling
Haematologica|October 12, 2012
Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemiaStefan Fröhling
Hemasphere|November 15, 2019
Many Roads Lead to snoRNAs: The Ever-Expanding Universe of Non-Coding RNAs in Acute Myeloid LeukemiaStefan Fröhling
Haematologica|August 3, 2012
Ligand-induced MET signaling as targetable codependence in acute myeloid leukemiaStefan Fröhling
The New England Journal of Medicine|December 3, 2004
Disruption of C/EBPalpha function in acute myeloid leukemiaStefan Fröhling, Hartmut Döhner
Seminars in Oncology|February 1, 2012
Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insightsLars Bullinger, Stefan Fröhling
Cancer Research|December 1, 2011
STK33 kinase is not essential in KRAS-dependent cells--letterStefan Fröhling, Claudia Scholl
The New England Journal of Medicine|August 16, 2008
Chromosomal abnormalities in cancerStefan Fröhling, Hartmut Döhner
Cancer Discovery|January 12, 2024
Measuring Progress in Precision OncologyPeter Horak, Stefan Fröhling
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Molecular & Cellular Oncology|April 14, 2022
Interdisciplinary team science to understand and intercept rare cancersStefan Fröhling
Med (New York, N.Y.)|December 10, 2022
Toward defining the clinically actionable genome of metastatic breast cancerStefan Fröhling
Haematologica|October 12, 2012
Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemiaStefan Fröhling
Hemasphere|November 15, 2019
Many Roads Lead to snoRNAs: The Ever-Expanding Universe of Non-Coding RNAs in Acute Myeloid LeukemiaStefan Fröhling
Haematologica|August 3, 2012
Ligand-induced MET signaling as targetable codependence in acute myeloid leukemiaStefan Fröhling
The New England Journal of Medicine|December 3, 2004
Disruption of C/EBPalpha function in acute myeloid leukemiaStefan Fröhling, Hartmut Döhner
Seminars in Oncology|February 1, 2012
Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insightsLars Bullinger, Stefan Fröhling
Cancer Research|December 1, 2011
STK33 kinase is not essential in KRAS-dependent cells--letterStefan Fröhling, Claudia Scholl
The New England Journal of Medicine|August 16, 2008
Chromosomal abnormalities in cancerStefan Fröhling, Hartmut Döhner
Cancer Discovery|January 12, 2024
Measuring Progress in Precision OncologyPeter Horak, Stefan Fröhling
Pageof 31